Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland · 2026
Efficacy of home biofeedback in dyssynergic defaecation: A prospective pilot study.
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Omak Ahmet, Bulut Alisina, Attaallah Wafi
Аннотация
AIM: To evaluate the effectiveness of home biofeedback therapy in patients with dyssynergic defaecation.
METHOD: This single-centre prospective cohort study was conducted in a tertiary general surgery outpatient clinic. Adult patients with dyssynergic defaecation confirmed according to Rome IV criteria and physiological testing were prospectively enrolled after ethical approval. Participants received training on the use of a home-based anal biofeedback device and performed biofeedback exercises at home for 30 min daily over a 12-week period. Changes in Obstructed Defaecation Syndrome Score (ODS-S) and Patient Assessment of Constipation Quality of Life (PAC-QoL) score were evaluated.
RESULTS: Twenty-four patients were included in the study. The median ODS-S significantly improved from 17.5 (range, 13-20) at baseline to 3 (range, 0-12) after treatment (P < 0.001). The median PAC-QoL score also showed a significant improvement, decreasing from 104 (range, 65-126) to 49 (range, 32-81) (P < 0.001). Clinical improvement, defined as an ODS-S < 9, was achieved in 75% of patients.
CONCLUSION: Home-based biofeedback therapy is an effective and accessible treatment option for dyssynergic defaecation. Its low cost, ease of use and ability to preserve patient privacy suggest that this modality may serve as a practical first-line therapy.
METHOD: This single-centre prospective cohort study was conducted in a tertiary general surgery outpatient clinic. Adult patients with dyssynergic defaecation confirmed according to Rome IV criteria and physiological testing were prospectively enrolled after ethical approval. Participants received training on the use of a home-based anal biofeedback device and performed biofeedback exercises at home for 30 min daily over a 12-week period. Changes in Obstructed Defaecation Syndrome Score (ODS-S) and Patient Assessment of Constipation Quality of Life (PAC-QoL) score were evaluated.
RESULTS: Twenty-four patients were included in the study. The median ODS-S significantly improved from 17.5 (range, 13-20) at baseline to 3 (range, 0-12) after treatment (P < 0.001). The median PAC-QoL score also showed a significant improvement, decreasing from 104 (range, 65-126) to 49 (range, 32-81) (P < 0.001). Clinical improvement, defined as an ODS-S < 9, was achieved in 75% of patients.
CONCLUSION: Home-based biofeedback therapy is an effective and accessible treatment option for dyssynergic defaecation. Its low cost, ease of use and ability to preserve patient privacy suggest that this modality may serve as a practical first-line therapy.